The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...

For people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher ...

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

Exelixis, Inc. EXEL announced that the District Court of Delaware has ruled in its favor in the second patent litigation ...

The Department of Pharmaceuticals (DoP) has dismissed two review applications filed by Abbott Healthcare Private Limited ...

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.

While Citi has maintained its 'buy' call for Cipla, it noted that a further delay in resolving issues at the Goa facility ...

A media report said that the US Center for Medicare and Medicaid released a preliminary list of 101 generic drugs.

Pharma Industry revenue growth is likely to grow by 85 per cent YoY and will be driven by domestic formulations and niche ...

These debt-free giants offer valuable insights into what it takes to succeed without relying on borrowed money.

Prescription Hair Loss and Hair Removal Drugs Market Prescription Hair Loss and Hair Removal Drugs Market is expected to reach USD 48.11 Bn by 2031, exhibiting a CAGR of 6.9% from 2024 to 2031. BURLIN ...